FDA-Approved MedicationUpdated October 2026

Mounjaro Guide

Mounjaro is Eli Lilly's brand of tirzepatide, a once-weekly shot. Its label covers blood-sugar control in type 2 diabetes from age 10 up, plus fewer major heart events (heart attack, stroke, cardiovascular death) for diabetic adults whose risk of them is high. Weight loss is not on that label: Lilly sells the same molecule for weight as Zepbound, though some doctors still write Mounjaro off-label for it.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

At a Glance

Mounjaro at a glance
Generic NameTirzepatide
Brand NamesMounjaro
FDA StatusFDA-approved for type 2 diabetes in adults (May 2022) and in children 10 and older (December 2025), and to reduce major cardiovascular events in adults with type 2 diabetes at high risk (August 2026). Off-label use for weight loss is common; the weight management indication is covered by Zepbound (FDA-approved November 2023).[1]
Approval DateMay 13, 2022[1]

How does Mounjaro work?

Mounjaro's tirzepatide activates both GIP and GLP-1 receptors — making it a "dual agonist" or "twincretin." For diabetes, this dual action powerfully lowers blood sugar by increasing insulin secretion and reducing glucagon. The same pathways simultaneously reduce appetite, slow gastric emptying, and appear to act directly on fat cells — producing the highest weight loss rates of any approved medication.[2][3]

Dosing Schedule

Mounjaro uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].

Weeks 1–42.5mg/week
Weeks 5–85mg/week
Weeks 9–127.5mg/week
Weeks 13–1610mg/week
Weeks 17–2012.5mg/week
Week 21+15mg/week (max)

What side effects does Mounjaro cause?

Common: nausea (12–18%), diarrhea (13–16%), vomiting (5–9%), constipation (5–7%), decreased appetite, abdominal pain, injection site reactions. Side effects typically improve after the first 4–8 weeks. Serious (rare): pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury.[1][2]

Nothing above is the full list. Your prescriber can give you the complete safety picture, and every adverse reaction on record sits in the current FDA prescribing information[1].

Clinical Trial Results

In the SURPASS-2 trial, Mounjaro (tirzepatide 15mg) reduced HbA1c by 2.30 percentage points and produced 5.5 kg (about 12 lbs) more weight loss than semaglutide 1mg.[2]

Source: Published clinical trial data (STEP / SURMOUNT trial series) — see the Sources panel below for full citations.

Where can you get Mounjaro?

Sellers in our register that will dispense tirzepatide, or a compounded version of it, after an online consultation — shipped to your door.

8.8/ 10
Verified partner

altRX

Best for: compounded semaglutide from $89/month at the same price at every dose

★★★★☆8.8/10

Editorial score · methodology

$1,249/mo
BrandTirzepatideLegitScript Verified
Get StartedRead full altRX review →
8.1/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★★☆8.1/10

Editorial score · methodology

$299/mo+ care fee
BrandTirzepatide
Get StartedRead full Sesame Care review →
7.4/ 10
Verified partner

Wellorithm

Best for: compounded semaglutide at a flat $247 every 28 days, any dose

★★★★☆7.4/10

Editorial score · methodology

$1,399/moprepaid
BrandTirzepatide
Get StartedRead full Wellorithm review →
7.2/ 10
Verified partner

Oak

Best for: a choice of compounded injections, oral semaglutide and brand-name GLP-1s from one cash-pay checkout

★★★★☆7.2/10

Editorial score · methodology

$1,200/mo
BrandTirzepatideGlutathioneNAD+SermorelinLegitScript Verified
Get StartedRead full Oak review →
6.8/ 10
Verified partner

DudeMeds

Best for: compounded semaglutide at $175/month, prepaid as a 3-month kit

★★★☆☆6.8/10

Editorial score · methodology

$1,350/mo
BrandTirzepatideNAD+
Get StartedRead full DudeMeds review →
6.3/ 10
Verified partner

SkinnyRx

Best for: starting below a standard dose, with microdose tiers

★★★☆☆6.3/10

Editorial score · methodology

$1,400/mo
BrandTirzepatide
Get StartedRead full SkinnyRx review →

19 sellers in the register publish a price; the lowest starts at $299 a month, checked October 2026. What each one charges to start, cheapest at the top. Compounded tirzepatide from state-licensed 503A pharmacies is legal under federal compounding law when made for an individual patient[4], and the rules loosen further, to include bulk compounding by 503B outsourcing facilities, only while a molecule sits on the FDA Drug Shortage List[5]. An FSA or HSA will generally cover either kind of prescription, compounded or branded, under IRS Publication 502[6]. What you actually pay moves with your dose and with whatever promotion happens to be running.

Starting Mounjaro price per seller, cheapest first. Prices in USD per month; checked October 2026.
ProviderStarting PriceLink
Sesame Care$299/mo + care feeVisit
Noom$349/moVisit
Mochi Health$499/mo + membershipVisit
Vital Edge$835/moVisit
Synergy Rx$947/moVisit
Oak$1,200/moVisit
altRX$1,249/moVisit
Maximus$1,249.99/moVisit
Effecty$1,300/moVisit
Pallas Health$1,349/moVisit
Show all 19 Mounjaro sellers
Mounjaro sellers 11 to 19, cheapest first. Prices in USD per month.
DudeMeds$1,350/moVisit
AlyveRx$1,395/moVisit
Eve$1,399/moVisit
Layla$1,399/moVisit
Vytora Health$1,399/moVisit
Wellorithm$1,399/mo, prepaidVisit
SkinnyRx$1,400/moVisit
Corsica Health$1,499/moVisit
myRocky$1,509/mo + program feeVisit

Short verdict pages setting Mounjaro against the other GLP-1 options, working from the trial results, the dose ladders on each label, and what the manufacturers charge today.

See all drug-vs-drug verdicts.

Questions people actually asked about Mounjaro in named subreddits, each answered from the published trial data.

One-screen references for the dose schedule, what to do about a missed dose, and the side effects that warrant a call. Every figure checked against the DailyMed label.

The peer-reviewed studies on Mounjaro and its neighbours that carry the most weight, gathered into lists. Every PMID was checked against PubMed esummary rather than recalled.

Longer pieces written here, built on the trial papers themselves, checked against the FDA label, and argued rather than summarized.

503A vs 503B Compounding Pharmacies: Who Oversees Your Compounded GLP-1
A 503A pharmacy compounds per patient under a state board. A 503B outsourcing facility registers with FDA, follows CGMP, is inspected and must report adverse events. What each means for compounded GLP-1s, and how to check yours.
10 min read12 citations
The Head-to-Head, and What It Settles
751 adults randomized to tirzepatide or semaglutide, each at maximum tolerated dose, for 72 weeks. Tirzepatide produced 20.2% weight loss against 13.7%, and on several other endpoints the answer runs the other way.
7 min read3 citations
Switching Between GLP-1 Drugs
No label contains a dose equivalence between semaglutide and tirzepatide, because no regulator has been asked to approve one. Every conversion chart online is somebody's arithmetic.
5 min read3 citations
Tirzepatide vs Dulaglutide: A Real Head-to-Head
13,299 people randomized to one drug or the other, followed four years. Kidney events occurred in 6.0% on tirzepatide against 7.6% on dulaglutide, and nausea, vomiting and diarrhea were all more common on tirzepatide.
6 min read1 citation
Does Your GLP-1 Wear Off Before the Next Dose?
Half of each dose is still present when the next one is due. The label puts semaglutide's elimination half-life at roughly seven days, tirzepatide's at about five. That is a slope, not a cliff.
6 min read2 citations
GLP-1 Drugs and Type 1 Diabetes: The Label Says Unevaluated. Three Trials Disagree.
36% of people with type 1 diabetes and obesity hit a composite of time-in-range, low-glucose safety and 5% weight loss, against 0% on placebo. Total daily insulin fell about a third in a second trial.
7 min read9 citations

Frequently Asked Questions

FDA-approved for type 2 diabetes in adults (May 2022) and in children 10 and older (December 2025), and to reduce major cardiovascular events in adults with type 2 diabetes at high risk (August 2026). Off-label use for weight loss is common; the weight management indication is covered by Zepbound (FDA-approved November 2023).
What you pay for Mounjaro turns on who is selling it and in what form. Uninsured, the branded product runs roughly $1,000 to $1,600 a month; compounded versions through telehealth sellers usually land between $129 and $400. The table above carries the current figures from our register. Before you commit, check whether a manufacturer savings program applies to you.
Common: nausea (12–18%), diarrhea (13–16%), vomiting (5–9%), constipation (5–7%), decreased appetite, abdominal pain, injection site reactions. Side effects typically improve after the first 4–8 weeks. Serious (rare): pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury.
Mounjaro is prescription-only, so someone licensed has to write it — your own doctor, an endocrinologist, or one of the telehealth sellers above. For compounded versions the telehealth route is usually both quicker and cheaper out of pocket than a traditional pharmacy.
Sources & methodology — as of November 2026
  1. 1.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  2. 2.SURPASS-2 Trial — Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (Frías JP et al.)— New England Journal of Medicine.PMID: 34170647.
  3. 3.ADA — Standards of Care in Diabetes (2025)— American Diabetes Association.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  6. 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Glossary

The words sellers use, defined. Tap any term.